Danish National Genome Center selects Qiagen software for variant interpretation

Dna Sequencing Social

Qiagen on Tuesday said that its variant interpretation and reporting software, Qiagen Clinical Insight (QCI) Interpret, is being deployed as a part of a national initiative in Denmark to offer sequencing for cancer patients.

The Danish National Genome Center selected QCI Interpret to provide interpretation of oncology results generated from whole-genome sequencing (WGS) data, Qiagen said.

The initiative is part of a larger personalized medicine strategy that aims to provide WGS as a standard-of-care for relevant patient groups throughout Denmark.

Qiagen noted that Denmark is one of the first countries in the world to implement WGS as standard-of-care for oncology at this scale.

“Denmark is taking a visionary approach to aggregating genomic data and combining it with clinical information on cancer patients to develop enhanced population-specific knowledge and reference sets for the country’s residents,” Jonathan Sheldon, executive vice president and head of Qiagen Digital Insights, said in a statement. “This will serve as a foundation for effective precision medicine capabilities for years to come.“

Page 1 of 49
Next Page